stocktrader

Givaudan beats sales estimates as fragrance demand lifts shares

Swiss fragrance and flavour maker Givaudan reported stronger-than-expected first-quarter sales growth, supported by robust demand in its fragrance and consumer products segment. The company said its LFL sales rose 2.8% in the quarter. This excludes the impact of currency fluctuations, acquisitions, and disposals. This figure came in above a company-compiled consensus forecast of 1.9%. Analysts… Continue reading Givaudan beats sales estimates as fragrance demand lifts shares

Top reasons a United Airlines and American merger is unlikely to happen

The United Airlines (UAL) and American Airlines (AAL) stocks will be in the spotlight today, April 14, as investors react to news of a potential mega-merger. AAL has dropped to $11.25, down by over 30% from its highest point last year. Similarly, United Airlines has dropped to $95, down by 20% from the same period… Continue reading Top reasons a United Airlines and American merger is unlikely to happen

What’s behind BP’s exceptional Q1 forecast, and debt surge with it?

BP is heading into its first-quarter results with an unusually strong message on earnings, but also with a less comfortable one on the balance sheet. The oil major said on Tuesday that its oil trading business is expected to deliver “exceptional” results in the first quarter. The forecasts are helped by the violent swings that… Continue reading What’s behind BP’s exceptional Q1 forecast, and debt surge with it?

Novo Nordisk taps OpenAI to boost AI in drug development

Novo Nordisk on Tuesday announced a partnership with OpenAI to deploy artificial intelligence across its business, spanning drug discovery, manufacturing and commercial operations, as the Danish drugmaker looks to sharpen its competitive edge in the fast-growing obesity drug market. The company said the collaboration would leverage OpenAI’s technology to analyse complex datasets, identify promising drug… Continue reading Novo Nordisk taps OpenAI to boost AI in drug development

Why is OpenAI’s $852B valuation facing investor scrutiny?

OpenAI’s massive $852 billion valuation is coming under scrutiny from some of its own investors as the company pivots its focus toward enterprise offerings, according to a report by the Financial Times published on Tuesday. The concerns emerge as the company pivots towards enterprise-focused offerings in an effort to counter rising competition. The shift in… Continue reading Why is OpenAI’s $852B valuation facing investor scrutiny?

Barclays names European airline stocks you cannot afford to miss

Barclays has picked out IAG and Ryanair as its preferred names in Europe’s airline sector and argued that elevated fuel costs are doing more than squeezing margins. They are beginning to redraw the competitive map. At a moment when the world is facing oil volatility, supply disruption, and fare pressure, the broker’s call is effectively… Continue reading Barclays names European airline stocks you cannot afford to miss

Top crypto market predictions today: HYPE, XRP, and Algorand

The crypto market rallied today, April 14, as investors predicted that the US and Iran were escalating the rhetoric ahead of a de-escalation ahead of the ceasefire deadline. Bitcoin surged to $94,000, while the market cap of all tokens jumped by over 4%. This article provides a forecast for top altcoins like Hyperliquid (HYPE), Ripple… Continue reading Top crypto market predictions today: HYPE, XRP, and Algorand

Citi says European bank stocks are cheap, backs buying the dip

After a vintage 2025 that saw European bank valuations more than double in their best showing since 1997, the sector hit a geopolitical wall in March 2026. Tensions between the US and Iran triggered a sharp 10% correction in the Stoxx 600 Banks index, momentarily erasing three years of near-linear gains. However, Citi analysts are… Continue reading Citi says European bank stocks are cheap, backs buying the dip